ANASTROZOLE ERIS anastrozole 1 mg film-coated tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

anastrozole, Quantity: 1 mg

Commercializzato da:

Strides Pharma Science Pty Ltd

INN (Nome Internazionale):

Anastrozole

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: sodium starch glycollate; lactose monohydrate; hypromellose; magnesium stearate; povidone; titanium dioxide; macrogol 400

Via di somministrazione:

Oral

Confezione:

30 tablets

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

First line treatment of advanced breast cancer in postmenopausal women with oestrogen/progesterone receptor positive disease. Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with oestrogen receptor negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to ANASTROZOLE ERIS.

Dettagli prodotto:

Visual Identification: White to off-white, round, biconvex film coated tablet engraved with the letters "A 1" on one side and plain on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2012-09-24